One of these medicines, Eylea, also blocks another substance called placental growth factor (PlGF) and may be an option for people with wet AMD. As you age, you may develop a condition that causes ...

Eylea (aflibercept) is a biologic drug prescribed to help prevent vision loss in certain situations. It’s a liquid solution given by healthcare professionals as an injection into the eye. Eylea ...

Eylea (aflibercept) is a prescription injection that treats certain eye diseases. Eylea’s cost may depend on your treatment plan, whether you have health insurance, and which doctor’s office ...

A single-dose glass vial containing one Eylea HD 8 mg (0.07 mL of a 114.3 mg/mL solution); or A vial kit with the following components: one Eylea HD 8 mg (0.07 mL of a 114.3 mg/mL solution ...

Regeneron’s lead drug, Eylea (aflibercept), is an anti-vascular endothelial growth factor inhibitor approved for various ophthalmology indications. To counter the ongoing decline in Eylea sales ...

Credit: Getty Images. The approval was based on data from the phase 3 BUTTERFLEYE and FIREFLEYE trials. The Food and Drug Administration (FDA) has approved Eylea ® (aflibercept) for the treatment ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved Eylea for the treatment of retinopathy of prematurity in preterm infants, according to a ...

Aug 21 (Reuters) - A quicker-than-expected U.S. approval for Regeneron Pharmaceuticals' (REGN.O), opens new tab high-dose eye disease drug, Eylea, should help return the blockbuster treatment back ...